| 2021 |
| 01/20 | 15:00 第18回新株予約権(行使価額修正条項付)の大量行使に関するお知らせ |
| 01/19 | 10:00 米国臨床腫瘍学会消化器癌シンポジウムにおいてテロメライシン（OBP-301）と化学放射線療法併用Phase１医師主導治験のプロトコル概要に関する発表のお知らせ |
| 01/18 | 14:00 中外製薬によるテロメライシン(OBP-301)の開発進展に関するお知らせ |
| 01/18 | 1,405 | 1,493 | 1,391 | 1,402 | -0.85% | 711,300 | 205億1111万 | -5.21% |
| 01/15 | 1,406 | 1,440 | 1,388 | 1,414 | +0.64% | 356,700 | 206億8667万 | -5.1% |
| 01/14 | 1,442 | 1,516 | 1,405 | 1,405 | -3.57% | 462,500 | 205億5500万 | -6.4% |
| 01/14 | 9:00 テロメライシン(OBP-301)に関するアテゾリズマブ及びベバシズマブ併用の肝細胞がんを対象としたPhase1臨床試験FPI達成のお知らせ |
| 01/13 | 1,472 | 1,479 | 1,443 | 1,457 | -1.29% | 182,400 | 213億1576万 | -3.83% |
| 01/12 | 1,469 | 1,485 | 1,447 | 1,476 | +0.48% | 160,300 | 215億9373万 | -3.34% |
| 01/08 | 1,455 | 1,475 | 1,442 | 1,469 | +0.75% | 141,900 | 214億9132万 | -4.61% |
| 01/07 | 1,489 | 1,492 | 1,458 | 1,458 | -2.28% | 153,900 | 213億3039万 | -6.3% |
| 01/06 | 15:00 執行役員の異動に関するお知らせ |
| 01/06 | 1,491 | 1,522 | 1,491 | 1,492 | -0.67% | 163,700 | 218億2781万 | -4.85% |
| 01/05 | 1,500 | 1,518 | 1,474 | 1,502 | -0.6% | 82,800 | 219億7410万 | -4.88% |
| 01/04 | 15:00 第三者割当による第18回新株予約権(行使価額修正条項付)の発行に係る払込完了に関するお知らせ |
| 01/04 | 1,519 | 1,528 | 1,466 | 1,511 | +0.53% | 135,900 | 221億577万 | -5.09% |
| 2020 |
| 12/30 | 1,508 | 1,536 | 1,494 | 1,503 | -1.38% | 143,200 | 219億8873万 | -6.18% |
| 12/29 | 1,459 | 1,541 | 1,454 | 1,524 | +4.81% | 336,800 | 221億1522万 | -5.34% |
| 12/28 | 15:00 第三者割当による新株式発行の払込完了に関するお知らせ |
| 12/28 | 1,500 | 1,501 | 1,435 | 1,454 | -1.82% | 220,300 | 210億9943万 | -10.14% |
| 12/25 | 1,484 | 1,510 | 1,461 | 1,481 | -1% | 235,600 | 214億9123万 | -9.03% |
| 12/24 | 1,442 | 1,506 | 1,441 | 1,496 | +4.32% | 364,700 | 217億890万 | -8.61% |
| 12/23 | 1,392 | 1,436 | 1,392 | 1,434 | +2.65% | 217,000 | 208億920万 | -12.93% |
| 12/22 | 1,426 | 1,430 | 1,371 | 1,397 | -2.72% | 386,000 | 202億7228万 | -15.79% |
| 12/21 | 1,470 | 1,487 | 1,429 | 1,436 | -0.97% | 245,700 | 208億3822万 | -14.27% |
| 12/18 | 1,481 | 1,492 | 1,439 | 1,450 | -1.83% | 248,100 | 210億4138万 | -14.15% |
| 12/17 | 1,454 | 1,484 | 1,446 | 1,477 | +0.68% | 115,500 | 214億3319万 | -13.22% |
| 12/16 | 1,468 | 1,513 | 1,461 | 1,467 | -2.07% | 227,000 | 212億8807万 | -14.41% |
| 12/15 | 15:30 第三者割当による第18回新株予約権(行使価額修正条項付)の発行条件等の決定に関するお知らせ |
| 12/15 | 1,522 | 1,532 | 1,431 | 1,498 | -1.77% | 718,600 | 217億3792万 | -13.11% |
| 12/14 | 1,530 | 1,548 | 1,510 | 1,525 | 0% | 254,100 | 221億2973万 | -12.05% |
| 12/11 | 1,511 | 1,580 | 1,475 | 1,525 | -10.87% | 1,422,900 | 221億2973万 | -12.41% |
| 12/10 | 17:00 朝日インテック株式会社及びオンコリスバイオファーマ株式会社の資本業務提携に関するお知らせ |
| 12/10 | 17:00 新株式及び第18回新株予約権(行使価額修正条項付)の第三者割当による発行並びにファシリティ契約(行使停止指定条項付)の締結に関するお知らせ |
| 12/10 | 1,685 | 1,714 | 1,676 | 1,711 | +1.54% | 185,300 | 248億2883万 | -2.23% |
| 12/09 | 1,677 | 1,713 | 1,675 | 1,685 | -1.12% | 158,800 | 244億5154万 | -3.77% |
| 12/08 | 1,700 | 1,710 | 1,660 | 1,704 | -1.56% | 238,700 | 247億2725万 | -2.63% |
| 12/07 | 1,776 | 1,776 | 1,713 | 1,731 | -2.2% | 205,900 | 251億1906万 | -0.92% |
| 12/04 | 15:00 OBP-801の眼科領域への応用に関する京都府立医科大学との研究結果の論文掲載のお知らせ |
| 12/04 | 1,812 | 1,812 | 1,740 | 1,770 | -1.01% | 244,200 | 256億8500万 | +1.32% |
| 12/03 | 15:00 OBP-601のライセンス契約に基づく契約一時金受領のお知らせ |
| 12/03 | 1,874 | 1,885 | 1,780 | 1,788 | -4.64% | 368,600 | 259億4620万 | +2.52% |
| 12/02 | 12:00 国内外でのテロメライシン(OBP-301)の開発進展について |
| 12/02 | 1,760 | 1,926 | 1,760 | 1,875 | +6.41% | 755,700 | 272億868万 | +7.57% |
| 12/01 | 1,778 | 1,783 | 1,752 | 1,762 | -0.9% | 134,400 | 255億6891万 | +1.38% |
| 11/30 | 1,812 | 1,820 | 1,769 | 1,778 | -2.47% | 205,500 | 258億109万 | +2.42% |
| 11/27 | 1,799 | 1,832 | 1,768 | 1,823 | +3.23% | 393,600 | 264億5409万 | +5.13% |
| 11/26 | 1,810 | 1,845 | 1,736 | 1,766 | +4.5% | 748,400 | 256億2695万 | +2.02% |
| 11/25 | 17:05 OBP-601のライセンス契約に基づくマイルストーン達成のお知らせ |
| 11/25 | 1,714 | 1,735 | 1,689 | 1,690 | -1.86% | 116,200 | 245億2409万 | -2.37% |
| 11/24 | 1,720 | 1,744 | 1,701 | 1,722 | +1.12% | 167,600 | 249億8845万 | -0.86% |
| 11/20 | 1,708 | 1,709 | 1,677 | 1,703 | -0.12% | 119,700 | 246億4462万 | -2.07% |
| 11/19 | 1,742 | 1,744 | 1,680 | 1,705 | -3.4% | 242,700 | 246億7356万 | -2.57% |
| 11/18 | 1,720 | 1,778 | 1,720 | 1,765 | +2.14% | 133,500 | 255億4184万 | +0.17% |
| 11/17 | 1,779 | 1,794 | 1,726 | 1,728 | -3.03% | 247,100 | 250億640万 | -2.54% |
| 11/16 | 1,802 | 1,813 | 1,754 | 1,782 | -0.22% | 103,800 | 257億8785万 | -0.17% |
| 11/13 | 1,780 | 1,797 | 1,752 | 1,786 | +0.56% | 104,800 | 258億4574万 | -0.56% |
| 11/12 | 1,796 | 1,804 | 1,754 | 1,776 | -1.11% | 126,800 | 257億102万 | -1.82% |
| 11/11 | 1,743 | 1,802 | 1,736 | 1,796 | +5.03% | 219,000 | 259億9045万 | -1.37% |
| 11/10 | 1,725 | 1,755 | 1,694 | 1,710 | -2.17% | 169,100 | 247億4592万 | -6.81% |
| 11/09 | 1,689 | 1,748 | 1,673 | 1,748 | +2.64% | 299,900 | 252億9583万 | -5.51% |
| 11/06 | 15:00 営業外費用及び特別損失の計上に関するお知らせ |
| 11/06 | 15:00 2020年12月期第3四半期決算短信〔日本基準〕(非連結) |
| 11/06 | 15:00 報告セグメントの廃止に関するお知らせ |
| 11/06 | 1,705 | 1,739 | 1,689 | 1,703 | -1.96% | 172,000 | 246億4462万 | -8.64% |
| 11/05 | 1,742 | 1,768 | 1,711 | 1,737 | +0.12% | 125,800 | 251億3664万 | -7.56% |
| 11/04 | 1,666 | 1,740 | 1,666 | 1,735 | +4.83% | 156,600 | 251億770万 | -8.39% |
| 11/02 | 1,648 | 1,679 | 1,631 | 1,655 | +1.41% | 198,700 | 239億5000万 | -13.12% |
| 10/30 | 1,716 | 1,744 | 1,620 | 1,632 | -5.72% | 280,300 | 236億1716万 | -15.04% |
| 10/29 | 1,685 | 1,733 | 1,660 | 1,731 | +1.05% | 210,500 | 250億4982万 | -10.68% |
| 10/28 | 1,730 | 1,770 | 1,703 | 1,713 | -2.28% | 121,200 | 247億8933万 | -12.42% |
| 10/27 | 1,710 | 1,761 | 1,685 | 1,753 | +0.69% | 140,200 | 253億6818万 | -11.2% |
| 10/26 | 1,714 | 1,762 | 1,708 | 1,741 | +0.64% | 138,300 | 251億9453万 | -12.51% |
| 10/23 | 1,707 | 1,743 | 1,643 | 1,730 | +0.93% | 350,400 | 250億3534万 | -13.8% |
| 10/22 | 1,750 | 1,750 | 1,694 | 1,714 | -2.72% | 328,900 | 248億380万 | -15.23% |
| 10/21 | 1,737 | 1,796 | 1,737 | 1,762 | 0% | 168,500 | 254億9843万 | -13.46% |
| 10/20 | 1,799 | 1,813 | 1,741 | 1,762 | -3.56% | 301,500 | 254億9843万 | -14.01% |
| 10/19 | 1,785 | 1,836 | 1,736 | 1,827 | +2.41% | 274,900 | 264億3906万 | -11.27% |
| 10/16 | 1,975 | 1,982 | 1,770 | 1,784 | -9.85% | 992,400 | 258億1679万 | -13.69% |
| 10/15 | 1,998 | 2,012 | 1,961 | 1,979 | -1.44% | 333,300 | 286億3870万 | -4.76% |
| 10/14 | 2,017 | 2,035 | 2,003 | 2,008 | -0.84% | 185,300 | 290億5837万 | -3.37% |
| 10/13 | 2,040 | 2,040 | 2,000 | 2,025 | -1.03% | 217,800 | 293億438万 | -2.6% |
| 10/12 | 2,038 | 2,062 | 2,021 | 2,046 | +0.05% | 161,100 | 296億827万 | -1.68% |
| 10/09 | 2,100 | 2,114 | 2,031 | 2,045 | -2.67% | 285,500 | 295億9380万 | -1.73% |
| 10/08 | 2,101 | 2,126 | 2,076 | 2,101 | +0.77% | 171,500 | 304億420万 | +0.96% |
| 10/07 | 2,130 | 2,134 | 2,077 | 2,085 | -2.89% | 213,200 | 301億7266万 | +0.29% |
| 10/06 | 2,101 | 2,147 | 2,075 | 2,147 | +2.73% | 194,700 | 310億6988万 | +3.42% |
| 10/05 | 2,110 | 2,126 | 2,077 | 2,090 | -0.1% | 188,500 | 302億4501万 | +0.77% |
| 10/02 | 2,104 | 2,139 | 2,055 | 2,092 | +0.19% | 302,000 | 302億7395万 | +0.63% |
| 09/30 | 2,094 | 2,114 | 2,063 | 2,088 | -0.24% | 133,800 | 302億1607万 | +0.34% |
| 09/29 | 2,020 | 2,094 | 2,020 | 2,093 | +3.56% | 150,600 | 302億8843万 | +0.34% |
| 09/28 | 2,044 | 2,073 | 2,004 | 2,021 | -1.61% | 214,000 | 292億4649万 | -3.39% |
| 09/25 | 2,041 | 2,084 | 2,032 | 2,054 | -0.58% | 159,300 | 297億2405万 | -2.19% |
| 09/24 | 2,154 | 2,155 | 2,047 | 2,066 | -4.75% | 357,300 | 298億9770万 | -2.04% |
| 09/23 | 2,123 | 2,172 | 2,112 | 2,169 | +0.18% | 186,800 | 313億8824万 | +2.55% |
| 09/18 | 15:00 特別損失の発生に関するお知らせ |
| 09/18 | 2,150 | 2,165 | 2,126 | 2,165 | +0.23% | 149,900 | 313億3036万 | +2.36% |
| 09/17 | 2,182 | 2,184 | 2,112 | 2,160 | -0.6% | 302,100 | 312億5800万 | +2.03% |
| 09/16 | 2,090 | 2,173 | 2,078 | 2,173 | +3.97% | 300,600 | 314億4613万 | +2.45% |
| 09/15 | 2,076 | 2,099 | 2,052 | 2,090 | +0.67% | 124,700 | 302億4501万 | -1.46% |
| 09/14 | 2,088 | 2,101 | 2,057 | 2,076 | +0.39% | 181,800 | 300億4241万 | -2.26% |
| 09/11 | 2,041 | 2,072 | 1,991 | 2,068 | +2.83% | 238,900 | 299億2664万 | -2.64% |
| 09/10 | 2,045 | 2,061 | 1,998 | 2,011 | -1.42% | 159,800 | 291億178万 | -5.28% |
| 09/09 | 2,000 | 2,046 | 1,998 | 2,040 | -0.34% | 150,300 | 295億2145万 | -4.27% |
| 09/08 | 1,994 | 2,055 | 1,971 | 2,047 | +2.66% | 249,400 | 296億2275万 | -4.08% |
| 09/07 | 2,030 | 2,041 | 1,961 | 1,994 | -1.43% | 304,900 | 288億5577万 | -6.65% |
| 09/04 | 2,027 | 2,061 | 2,011 | 2,023 | -2.27% | 281,500 | 292億7543万 | -5.33% |
| 09/03 | 2,056 | 2,113 | 2,035 | 2,070 | +0.93% | 248,100 | 299億5559万 | -3.27% |
| 09/02 | 2,080 | 2,118 | 2,031 | 2,051 | -0.49% | 224,400 | 296億8063万 | -4.2% |
| 09/01 | 2,053 | 2,078 | 2,029 | 2,061 | +0.54% | 163,100 | 298億2534万 | -3.92% |
| 08/31 | 2,020 | 2,094 | 2,020 | 2,050 | +2.09% | 219,500 | 296億6616万 | -4.65% |
| 08/28 | 18:30 取締役の人事に関するお知らせ |
| 08/28 | 2,090 | 2,098 | 1,990 | 2,008 | -4.29% | 545,400 | 290億5837万 | -7.12% |
| 08/27 | 2,200 | 2,212 | 2,087 | 2,098 | -4.46% | 395,400 | 303億6078万 | -3.54% |
| 08/26 | 2,190 | 2,233 | 2,163 | 2,196 | +1.48% | 274,400 | 317億7897万 | +0.6% |
| 08/25 | 2,186 | 2,205 | 2,141 | 2,164 | -1.32% | 280,800 | 313億1589万 | -1.1% |
| 08/24 | 2,263 | 2,273 | 2,158 | 2,193 | -3.09% | 409,400 | 317億924万 | -0.18% |
| 08/21 | 15:00 譲渡制限付株式報酬としての自己株式の処分に関するお知らせ |
| 08/21 | 2,229 | 2,280 | 2,205 | 2,263 | +2.35% | 291,300 | 327億2139万 | +2.35% |
| 08/20 | 2,282 | 2,290 | 2,185 | 2,211 | -3.15% | 394,800 | 319億6951万 | -0.45% |
